Format

Send to

Choose Destination
Expert Rev Vaccines. 2006 Jun;5(3):347-63.

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

Author information

1
Box 3258, RP-1 Building, Building 107, Circuit Drive, Duke University Medical Center, Durham, NC 27710, USA. hayne002@mc.duke.edu

Abstract

Neutralizing antibody induction is a key feature of many effective vaccines and is the only immune response that has proven to be capable of completely blocking AIDS virus infection in animal models. Unfortunately, the extensive genetic variability and complex immune-evasion strategies of HIV-1 have thwarted all attempts to date at eliciting an effective neutralizing antibody response with candidate HIV-1 vaccine immunogens. Recent advances in our understanding of how these evasion strategies operate, coupled with growing progress in unravelling the structure and immunobiology of the viral envelope glycoproteins, are contributing to novel immunogen designs to overcome the many barriers to inducing protective antibodies against HIV-1.

PMID:
16827619
PMCID:
PMC2716009
DOI:
10.1586/14760584.5.3.347
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center